Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

Yonsei University1,000 enrolled

Overview

Venous thromboembolism(VTE) is the third most common cardiovascular complication among hospitalized patients, and can even cause death. VTE often occurs in intensive care patients and there had been many efforts to prevent such complication. The American College of Chest Physicians (ACCP) had published evidence-based clinical practice guideline for VTE prophylaxis. This study focuses on how VTE prophylaxis is being performed in both medical and surgical ICUs in a single University hospital, and sees the differences in such prophylactic patterns.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Venous Thromboembolism

Eligibility

Sex: ALLMin age: 20 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * ICU admitted patients Exclusion Criteria: * patients under 20 years old

Locations (1)

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine

Seoul, Seoul, South Korea

Outcomes

Primary Outcomes

number of patients prescribed with any measures of VTE prophylaxis in ICU

The object of this study is to see the percentage of ICU admitted patients prescribed with VTE prophylaxis, and analyze the adequacy of such prophylactic measure according to the international guideline. Moreover, difference between the VTE prophylaxis pattern of medical and surgical ICUs will also be seek for further analysis.

Time frame: at the time of ICU admission an expected average of 5 months (When VTE prophylaxis for each patient is being ordered)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.